Search Results 231-240 of 16787 for Orlistat

  1. Electrophysiological Biomarkers for Parkinson's Disease - Mayo Clinic

    This study will determine the validity of predictive and surrogate biomarkers for the detection of Parkinson's disease and Parkinson's disease cognitive decline ...

  2. Selinexor in Advanced Liposarcoma - Clinical Trials

    This is a randomized, multicenter, double-blind, placebo-controlled, Phase 2-3 study of patients diagnosed with advanced unresectable dedifferentiated ...

  3. A Study Comparing the Effective Use of a Compact MRI Scanner to Other Similar Scanners - Mayo Clinic

    The purpose of this study is to evaluate the performance of the new compact Magnetic Resonance Imaging (MRI) scanner compared to standard MR exams of the brain.

  4. Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in Type 1 and Type 2 Diabetes - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  5. A Study to Evaluate Visual Function in Fuchs Endothelial Corneal Dystrophy - Mayo Clinic

    The purpose of this study is to determine visual function in patients with Fuchs Endothelial Corneal Dystrophy (FECD) to understand when in the course of ...

  6. Weight loss Diet and exercise - Mayo Clinic

    Keeping a healthy weight is a balancing act. Calories play a large part. Weight loss comes down to burning more calories than are taken in from food.

  7. Gastroenterology and Hepatology - Clinical trials

    The objective of this study is to compare the central neural circuitry with fMRI (7T) in 30 asymptomatic healthy controls, 30 constipated patients without ...

  8. Fulvestrant (intramuscular route) - Mayo Clinic

    Fulvestrant injection is used to treat hormone-receptor (HR) positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer in ...

  9. JavaScript is disabled. In order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.

  10. Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 Days - Mayo Clinic

    About this study. Evaluate the safety, tolerability, and efficacy of 28 days of treatment with ALLN-177 for reducing urinary oxalate excretion in patients ...